Objective: Investigation of etiological factors in mental retardation (MR). Methods: On 471 adults (mean age 46 years; 92.6% males) living in an institution for the mentally retarded, clinical examination, cytogenetic and molecular studies and basic metabolic screening were performed. Results: Chromosomal abnormalities were found in 100 patients (21.2%). Of these, 87 had numerical autosomal abnormalities (all Down syndrome), 7 structural autosomal abnormalities and 6 numerical abnormalities of sex chromosomes. Monogenic disorders were diagnosed in 61 patients (13%): 14 autosomal dominant, 25 autosomal recessive and 22 X-linked conditions. In 1.7% (n = 8) of the patients a central nervous system (CNS) malformation was documented. Acquired CNS disorders were diagnosed in 69 patients (14.6%): a prenatal cause was found in 15 patients, a perinatal in 27 and a postnatal cause in 27. In 233 patients (49.5% of the total sample; 215 males and 18 females) idiopathic MR was present. In this group there were 2 patients with a high degree of consanguinity (incest). In one third (n = 73; 31.3%) of these patients there was a family history of MR (MR in first and second-degree relatives). Pedigree data were most compatible with X-linked MR in 35 males from 32 different families, i.e. 47.9% of the patients with idiopathic MR and family history of MR, and 15% of the total group of patients with idiopathic MR. Thus, X-linked inheritance was considered in a total group of 57 males, accounting for 12.1% of the total population: known X-linked disorders in 22 males and non-specific X-linked MR in 35 males. Minor anomalies were present in 41 patients (17.6%). Their presence was significantly associated with the severity of the MR. Neurological abnormalities were present in 47 patients (20.2%), with CNS dysfunction (central paresis, dyskinesia, ataxia) in 45 (19.3%). Seizures were present in one third of the patients (n = 78) and a statistically significant correlation between the level of MR and the presence of seizures was found. In the group of males with idiopathic MR, the number of males with the combination of microcephaly and micro-orchidism was higher than expected, but not statistically significant and the number of males with the combination of macrocephaly and macro-orchidism was statistically significantly increased (n = 5; 2.3%). Before systematic evaluation, only 21.8% (103/471) of the patients had a known diagnosis. After this survey, 50.5% (238/471) of the investigated patients had a definite diagnosis. Conclusion: Establishing the diagnosis in older mentally retarded patients is important in the prevention of medical complications and in the development of management strategies for the institution. Finally, it is the conditio sine qua non for genetic counseling of the respective families.

1.
Birch HG, Richardson SA, Baird D, Horobin G, Ilsley R: Mental Subnormality in the Community: A Clinical and Epidemiological Study. Baltimore, Williams & Wilkins, 1970.
2.
Rutter M, Tizard J, Whitmore K: Education, Health and Behaviour. London, Longman, 1970.
3.
Van Haasen PP, De Bruyn EEJ, Pijl Y, Poortinga Y, Spelberg H, Vander Steene G, Coetsier P, Spoelders-Claes R, Stinissen J: Wechsler Intelligence Scale for Children-Revised. Testing Study. Nederlandse uitgave (WISC-R). Lisse, Swets & Zeitlinger, 1986.
4.
Stinissen J, Vander Steene G: WPPSI: Wechsler Preschool and Primary Scale of Intelligence. Handleiding bij de Nederlandse aanpassing. Lisse, Swets & Zeitlinger, 1970.
5.
Schneider MJ, Loots GMP, Reuter J: Kent Infant Development Scale (KID-N). Nederlandse uitgave. Lisse, Swets & Zeitlinger, 1990.
6.
Van der Meulen BF, Smrkovsky M: Bayley Scales of Infant Development. Nederlandse uitgave (BOS 2–30). Lisse, Swets & Zeitlinger, 1983.
7.
Stinissen J: Terman-Merrill Intelligentieschaal-Vorm L-M. Leuven, Faculteit der Psychologie en Pedagogische Wetenschappen van de Katholieke Universiteit Leuven, 1965.
8.
APA (American Psychiatric Association): Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1964.
9.
Nellhaus G: Head circumference from birth to eighteen years. Practical composite international and interracial graphs. Pediatrics 1968;41:106–114.
10.
Tanner JM: Physical growth and development; in Forfar JO, Arneil GC (eds): Textbook of Pediatrics. Edinburgh: Churchill-Livingstone, 1978, pp 253–303.
11.
Bushby KMD, Cole T, Matthews JNS, Goodship JA: Centiles for adult head circumference. Arch Dis Child 67 1992;1286–1287.
12.
Hall JG, Froster-Iskenius UG, Allanson JE: Handbook of Normal Physical Measurements. New York, Oxford University Press, 1989.
13.
Carrié A, Jun L, Bienvenu T, Vinet M-C, McDonell N, Couvert P, Zemni R, Cardona A, Van Buggenhout G, Frints S, Hamel B, Moraine C, Ropers HH, Strom,T, Howel GR, Whittaker A, Ross MT, Kahn A, Fryns JP, Beldjord C, Marynen P, Chellly J: A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 1999;23:25–31.
14.
Hamel BCJ, Smits APT, van den Helm B, Smeets DFCM, Knoers NVAM, van Roosmalen T, Thoonen GHJ, Assman-Hulsmans CFCH, Ropers H-H, Mariman ECM, Kremer H: Four families (MRX43, MRX44, MRX45, MRX52) with nonspecific X-linked mental retardation: Clinical and psychometric data and results of linkage analysis. Am J Med Genet 1999;85:290–304.
15.
Czeizel A, Lányi-Engelmayer A, Klujber L, Métneki J, Tusnády G: Etiological study of mental retardation in Budapest, Hungary. Am J Ment Defic 1980;85:120–122.
16.
Thoene J, Higgins J, Krieger I, Schmickel R, Weiss L: Genetic screening for mental retardation in Michigan. Am J Ment Defic 1981;85:335–340.
17.
Fryns JP, Kleczkowska A, Dereymaeker AM, Hoefnagels M, Heremans G, Marien J, Van den Berghe H: A genetic-diagnostic survey in an institutionalized population of 173 severely mentally retarded patients. Clin Genet 1986;30:315–323.
18.
Dereymaeker AM, Fryns JP, Haegeman J, Deroover J, Van den Berghe H: A genetic-diagnostic survey in an institutionalized population of 158 mentally retarded patients. The Viaene experience. Clin Genet 1988;34:126–134.
19.
Fryns JP, Volcke Ph, Haspeslagh M, Beusen L, Van den Berghe H: A genetic diagnostic survey in an institutionalized population of 262 moderately mentally retarded patients. The Borgerstein experience. J Ment Defic Res 1990;34:29–40.
20.
Fryns JP, Holvoet M, Azou M, Van den Berghe H: Etiologisch-diagnostisch onderzoek bij jonge kinderen met matige en ernstige ontwikkelingsachterstand. Tijdschr Geneesk 1990;46:1457–1462.
21.
Volcke Ph, Dereymaeker AM, Fryns JP, Van den Berghe H: On the nosology of moderate mental retardation with special attention to X-linked mental retardation. A diagnostic genetic survey of 274 institutionalized moderately mentally retarded men. Genet Couns 1990;1:47–56.
22.
Haspeslagh M, Fryns JP, Holvoet M, Collen G, Dierck G, Baeke J, Van den Berghe H: A clinical, cytogenetic and familial study of 307 mentally retarded, institutionalized, adult male patients with special interest for fra(X) negative X-linked mental retardation. Clin Genet 1991;39:434–441.
23.
Volcke Ph, Fryns JP, Pyck K, Van den Berghe H: Ervaringen met systematisch etiologisch onderzoek in een schoolpopulatie van 57 kinderen met licht mentale handicap en/of zwakzinnigheid. Tijdschr Geneesk 1991;47:1359–1364.
24.
Farag TI, Al-Awadi SA, El Badramary MH, Aref MA, Kasrawi B, Krishna Murthy DS, el Khalifa MY, Yadav G, Marafie MJ, Bastaki L: Disease profile of 400 institutionalized mentally retarded patients in Kuwait. Clin Genet 1993;44:329–334.
25.
Temtamy SA, Kandil MR, Demerdash AM, Hassan WA, Meguid NA, Afifi HH: An epidemiological/genetic study of mental subnormality in Assiut Governorate, Egypt. Clin Genet 1994;46:347–351.
26.
Schaap C, Schrander-Stumpel CTRM, Colla-Pijkels ETS, Van Driessche J, Kusters R, Fryns JP: A genetic diagnostic survey in an institutionalized population of 116 moderately to severely mentally retarded male patients: The Rekem experience. Genet Couns 1995;6:251–258.
27.
Claes S: Localization of genetic factors for non-specific and syndromic X-linked mental retardation; thesis, Leuven, 1997.
28.
Devriendt K, Holvoet M, Fryns JP: Etiologisch-diagnostisch onderzoek bij 66 volwassen personen met mentale handicap verblijvend in een bezigheidstehuis. Tijdschr Geneesk 1998;54:921–925.
29.
Félix TM, Leite JCL, Maluf SW, Coelho JC: A genetic diagnostic survey in a population of 202 mentally retarded institutionalized patients in the south of Brazil. Clin Genet 1998;54:219–223.
30.
Lantigua-Cruz A, Mora F, Arechaederra M, Rojas I, Morales E, Rodríguez H, Viñas C, Noa CE, Barrios B: Etiological characterization of 512 severely mentally retarded institutionalized patients in Havanna. Community Genet 1999;2:184–189.
31.
Mounod R-L, Klein D, Bettschart W, Cabrol C: A clinical and cytogenetic investigation carried out in a special institution for mentally retarded patients. Preliminary results concerning 82 cases of oligophrenia. J Génét Hum 1976;24:297–335.
32.
Speed RM, Johnston AW, Evans HJ: Chromosome survey of a total population of mentally subnormal in North-East of Scotland. J Med Genet 1976;13:295–306.
33.
Sutherland GR, Murch AR, Gardiner AJ, Couter RF, Wiseman C: Cytogenetic survey of a hospital for the mentally retarded. Hum Genet 1976;34:231–245.
34.
Jacobs P, Matsuura J, Mayer M, Newlands I: A cytogenetic survey of an institution for the mentally retarded. I. Chromosome abnormalities. Clin Genet 1978;13:37–60.
35.
Ally FE, Grace HJ: Chromosome abnormalities in South African mental retardates. S Afr Med J 1979;55:710–712.
36.
Gripenberg U, Hongell K, Knuutila S, Kähkönen M, Leisti F: A chromosome survey of 1,062 mentally retarded patients. Evaluation of a long-term study at the Rinnekoti Institution, Finland. Hereditas 1980;92:223–228.
37.
Kondo I, Hamaguchi H, Nakajima S, Haneda T: A cytogenetic survey of 449 patients in a Japanese institution for the mentally retarded. Clin Genet 1980;17:177–182.
38.
Nelson MM, Smart RD: The results of chromosome examinations in an institution for mental retardates in the Cape Province. S Afr Med J 1982;62:25–29.
39.
Brøndum-Nielsen K, Dyggve HV, Knudsen H, Olsen J: A chromosomal survey of an institution for the mentally retarded. Dan Med Bull 1983;30:5–13.
40.
Fryns JP, Kleczkowska A, Kubién E, Van den Berghe H: Cytogenetic findings in moderate and severe mental retardation. A study of an institutionalized population of 1991 patients. Acta Paediatr Scand 1984(Suppl 313).
41.
Schreppers-Tijdink GAJ, Curfs LMG, Wiegers A, Kleczkowska A, Fryns JP: A systematic cytogenetic study of a population of 1,170 mentally retarded and/or behaviourly disturbed patients including fragile X-screening. The Hondsberg experience. J Génét Hum 1988;36:425–446.
42.
English CJ, Davison EV, Bhate MS, Barett L: Chromosome studies of males in an institution for the mentally handicapped. J Med Genet 1989;26:379–381.
43.
Van Buggenhout GJCM, Trommelen JCM, Schoenmaker A, De Bal C, Verbeek JJMC, Smeets DFCM, Ropers HH, Devriendt K, Hamel BCJ, Fryns JP: Down syndrome in a population of elderly mentally retarded patients: Genetic-Diagnostic Survey and Implications for Medical Care. Am J Med Genet 1999;85:376–384.
44.
Harper P: Practical Genetic Counselling, ed 4. Oxford, Butterworth-Heinemann, 1993.
45.
Jones KL: Smith’s recognizable patterns of human malformation, ed 5. Philadelphia, Saunders, 1997.
46.
Borghgraef M, Fryns J-P, Van den Berghe H: The 48,XXYY syndrome. Follow-up data on clinical characteristics and psychological findings in 4 patients. Genet Couns 1991;2:103–108.
47.
Zlotogora J, Sagi M, Schuper A, Leiba H, Merin S: Variability of Stickler syndrome. Am J Med Genet 1992;42:337–339.
48.
Suyugül Z, Seven M, Hacihanefioglu S, Kartal A, Suyugul N, Cenai A: Anophthalmia-Waardenburg syndrome: A report of three cases. Am J Med Genet 1996;62:391–397.
49.
van Bokhoven H, Jung M; Smits APT, van Beersum S, Ruschendorf F, van Steensel M, Veenstra M, Tuerlings JHAM, Mariman ECM, Brunner HG, Wienker TF, Reis A, Ropers H-H, Hamel BCJ: Limb mammary syndrome: A new genetic disorder with mammary hypoplasia, ectrodactyly, and other hand/foot anomalies maps to human chromosome 3q27. Am J Hum Genet 1999;64:538–546.
50.
Celli J, Duijf P, Hamel BCJ, Bamshad M, Kramer B, Smits APT, Newbury-Ecob R, Hennekam RCM, Van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H: Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999;99:143–153.
51.
Schmidt M, Salzano FM: New case of an EEC-like syndrome in twins. Acta Genet Med Gemellol (Roma) 1988;37:347–350.
52.
Roelfsema NM, Cobben JM: The EEC syndrome: A literature study. Clin Dysmorphol 1996;5:115–27.
53.
Seno H, Yanai A, Sugino H, Inoue M, Takei T, Miyake I: Ectrodactyly, ectodermal dysplasia, and cleft lip syndrome. Scand J Plast Reconstr Surg Hand Surg 1996;30:227–230.
54.
Vincent C, Kalatzis V, Compain S, Levilliers J, Slim R, Graia F, Pereira ML, Nivelon A, Croquette MF, Lacombe D: A proposed new contiguous gene syndrome on 8q consists of branchio-oto-renal (BOR) syndrome, Duane syndrome, a dominant form of hydrocephalus and trapeze aplasia; implications for the mapping of the BOR gene. Hum Mol Genet 1994;3:1859–1866.
55.
Van Buggenhout GJCM, van Ravenswaaij-Arts CMA, Renier WO, van de Wiel MP, Trommelen JCM, Pijkels E, Hamel BCJ, Fryns JP: Fountain syndrome: Further delineation of the clinical syndrome and follow-up data. Genet Couns 1996;7:177–186.
56.
Van Buggenhout G, Trommelen J, Hamel B, Fryns JP: Björnstad syndrome in a patient with mental retardation. Genet Couns 1998;9:201–204.
57.
Van Buggenhout G, Trijbels J, Wevers R, Trommelen J, Brunner H, Hamel B, Fryns JP: Metabolic studies in older mentally retarded patients: Significance of metabolic testing and correlation with the clinical phenotype. Genet Couns 2001;12:1–21.
58.
Stevenson RE, Schwartz CE, Schroer RJ: X-Linked Mental Retardation. Oxford, Oxford University Press, 2000.
59.
Fryns JP, Haspeslagh M, Dereymaeker AM, Volcke Ph, Van den Berghe H: A peculiar subphenotype in the fra(X) syndrome: Extreme obesity – short stature – stubby hands and feet – diffuse hyperpigmentation: Further evidence of disturbed hypothalamic dysfunction in the fra(X) syndrome? Clin Genet 1987;32:388–392.
60.
Schrander-Stumpel C, Gerver W-J, Meyer H, Engelen J, Mulder H, Fryns J-P: Prader-Willi-like phenotype in fragile X syndrome. Clin Genet 1994;45:175–180.
61.
Lujan E, Carlin ME, Lubs HA: A form of X-linked mental retardation with marfanoid habitus. Am J Med Genet 1984;17:311–322.
62.
Fryns J-P, Buttiens M: X-linked mental retardation with marfanoid habitus. Am J Med Genet 1987;28:267–274.
63.
Åkesson HO: Cutis verticis gyrata, thyroaplasia and mental deficiency. Acta Genet Med Gemellol (Roma) 1965;14:200.
64.
Åkesson HO, Rayner S: Epiloia and cutis verticis gyrata. J Ment Defic Res 1968;12:9–12.
65.
De Boulle K, Verkerk A, Reyniers E, Vits L, Hendrickx J, Van Roy B, Van Den Bos F, de Graaff E, Oostra B, Willems P: A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 1993;3:31–35.
66.
Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, Cunniff C, Graham JM Jr, Jones MC, Kaback MM, Moeschler J, Schaefer GB, Schwartz S, Tarleton J, Opitz J: Evaluation of mental retardation: Recommendations of a consensus conference (American College of Medical Genetics). Am J Med Genet 1997;72:468–477.
67.
Warburg M: Visual impairment among people with developmental delay. J Intellect Dis Res 1994;38:423–432.
68.
Evenhuis HM: Medical aspects of ageing in a population with intellectual disability. II. Hearing impairment. J Intellect Dis Res 1995;39:27–33.
69.
Van Schrojenstein Lantman-de Valk HMJ, Akker M van den, Maaskant MA, Haveman MJ, Urlings HFJ, Kessels AGH, Crebolder HFJM: Prevalence and incidence of health problems in people with intellectual disability. J Intellect Dis Res 1996;40:535–543.
70.
Van Schrojenstein Lantman-de Valk H: Health problems in people with intellectual disability. Aspects of morbidity in residential settings and primary health care; thesis, Maastricht, 1998.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.